196 related articles for article (PubMed ID: 4342406)
1. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
Han T; Takita H
Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
[No Abstract] [Full Text] [Related]
2. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
Takita H; Brugarolas A
J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
[No Abstract] [Full Text] [Related]
3. Immunologic status in lung cancer.
Brugarolas A; Takita H
Chest; 1973 Oct; 64(4):427-30. PubMed ID: 4355273
[No Abstract] [Full Text] [Related]
4. In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
Han T
J Surg Oncol; 1973 Jun; 5(6):567-74. PubMed ID: 4129688
[No Abstract] [Full Text] [Related]
5. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
Piacentini G; Ferrari S; Megale C; Ippoliti F
Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
[No Abstract] [Full Text] [Related]
6. Immunocompetence of patients with bronchogenic carcinoma.
Olkowski ZL; McLaren JR; Mansour KA
Ann Thorac Surg; 1976 Jun; 21(6):546-51. PubMed ID: 179484
[TBL] [Abstract][Full Text] [Related]
7. [Immune status of patients with bronchial cancer].
Aulenbacher P; Manke HG; Drings P
Klin Wochenschr; 1987 May; 65(10):445-52. PubMed ID: 3037180
[TBL] [Abstract][Full Text] [Related]
8. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
9. Proceedings: Evaluation of immune status in tumor patients.
Vetto RM; Burger DR; Lilley DP
Arch Surg; 1974 Apr; 108(4):558-60. PubMed ID: 4131415
[No Abstract] [Full Text] [Related]
10. Tumor associated antigen with pulmonary neoplasms.
Lo Gerfo P; Herter FP; Braun J; Hansen HJ
Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
[No Abstract] [Full Text] [Related]
11. Mixed lymphocyte reactivity of patients with solid tumors.
Harris J; Stewart TH
Oncology; 1974; 30(1):33-42. PubMed ID: 4280032
[No Abstract] [Full Text] [Related]
12. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.
Sample WF; Gertner HR; Chretien PB
J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049
[No Abstract] [Full Text] [Related]
13. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
14. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
Pierce GE; DeVald B
Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation by bronchial lavage cells in normal individuals and patients with bronchogenic carcinoma.
Weissman DN; deShazo RD; Banks DE; Baser Y
Am J Med Sci; 1986 Oct; 292(4):187-92. PubMed ID: 3019138
[TBL] [Abstract][Full Text] [Related]
16. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
Takita H; Brugarolas A
J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
[No Abstract] [Full Text] [Related]
17. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
[TBL] [Abstract][Full Text] [Related]
18. Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders.
Dellon AL; Ptovin C; Chretien PB
Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):500-11. PubMed ID: 164781
[No Abstract] [Full Text] [Related]
19. In vitro methods of assessing lymphocyte transformation in patients undergoing radiotherapy for bronchogenic cancer.
Jenkins VK; Olson MH; Ellis HN
Tex Rep Biol Med; 1973; 31(1):19-28. PubMed ID: 4708575
[No Abstract] [Full Text] [Related]
20. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
